CPP Investments Increases Commitment to Canadian Market through Northleaf Capital Partners January 16, 2026 Canada Pension Plan Investment Board (CPP Investments) and Northleaf Capital Partners (Northleaf) today announced a significant expansion of their longstanding Canadian investment partnership, supporting the growth and scaling of domestic private companies. CPP Investments has committed to invest an additional C$750 million through its established Canadian mid-market program managed by Northleaf, bringing CPP Investments’ cumulative [...]
TNS Expands Global Market Data Access with Connectivity to Japan Alternative Market January 16, 2026 Transaction Network Services (TNS) has expanded its global market data and infrastructure footprint in the Asia-Pacific (APAC) region by adding connectivity to the Japan Alternative Market (JAX). This new connection provides TNS customers with direct, managed access to JAX’s market data feeds, delivered across TNS’ extensive global network. JAX began operations in December 2024, adding [...]
KiddeFenwal Launches NATURA™ Micro, Offering Enhanced, Compact Object Fire Protection for Vital Commercial and Industrial Assets January 16, 2026 Unveiling coincides with the introduction of sound- and vibration-dampening acoustic nozzles and additional NATURA™ “total flood” inert gas system enhancements at Intersec
AWS Launches AWS European Sovereign Cloud and Announces Expansion Across Europe January 16, 2026 AWS announces the general availability of the AWS European Sovereign Cloud and plans to expand across Europe with new AWS Local Zones in Belgium, the Netherlands, and Portugal Amazon plans to invest more than €7.8 billion in the AWS European Sovereign Cloud in Germany and support an average of 2,800 full-time equivalent jobs annually
Gravity Doesn’t Stand A Chance January 16, 2026 Rimmel London & Red Bull Deliver Gravity Defying Lashes & Thrilling Beam Routine Stunt Beauty brand Rimmel London has joined forces with Red Bull to launch the new Rimmel Thrill Seeker Mega Lift Mascara, taking a collegiate athlete to new heights with lashes lifted from every angle. In Red Bull’s first partnership with Rimmel London, Lily Smith takes on the gravity-defying challenge with confidence and style, and lashes as bold as her routine. The beautifully bold gymnastic balance beam routine was set 52 stories above the streets, which gave Red Bull gymnast Lily Smith wings to reach new heights!
New Cloudflare Report Warns of a ‘Technical Glass Ceiling’ Stifling AI Growth and Weakening Cybersecurity January 16, 2026 New research shows that organizations modernizing apps are 3x more likely to see AI payoffs, while those clinging to legacy systems face rising security risks and developer talent shortages
500 Global Announces Promotion of Mei Chel Tan to Global Managing Partner January 16, 2026 Appointment reflects expanding demand for entrepreneurial ecosystem development and AI readiness across emerging markets.
Accertify Appoints CEO and Expands Executive Team to Fuel Next Phase of Growth January 16, 2026 Greg Dukat appointed CEO as Accertify builds leadership depth to accelerate go-to-market execution
Barrows Connected Store Appoints James Hay as Global CEO January 16, 2026 Barrows Connected Store, a global leader in connected retail experiences, today announced the appointment of James Hay as Global Chief Executive Officer, effective January 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114778548/en/ In his new role, Hay will lead the global Barrows Connected Store business, encompassing teams in the UK, [...]
Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference January 16, 2026 Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 additional studies to be initiated in 2026. Almirall’s sustained trajectory of growth and profitability enables the company to reach more patients and supports a growth outlook of double-digit net sales through 2030, combined biologics peak sales of approximately €800 MM (Ebglyss® and Ilumetri®), and a 25% EBITDA margin by 2028. Almirall's leadership in medical dermatology, biologics growth, and continued strong performance of its broad product portfolio fuel advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need.